Keeping Current CME podcast

Unpacking New Data From 2024 Congresses on Transthyretin Amyloid Cardiomyopathy

0:00
32:29
Recuar 15 segundos
Avançar 15 segundos

Are you up to date on the new developments for emerging therapies for your patients with transthyretin amyloid cardiomyopathy (ATTR-CM)?

Credit available for this activity expires: 12/16/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002007?ecd=bdc_podcast_libsyn_mscpedu

Mais episódios de "Keeping Current CME"